Note: Ingredients listed on restricted chemical lists
General Information
Version
7.1
Revision date
2023-06-02
Product name
4-Nitrophenol
CAS No.
100-02-7
REACH No
is
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H302+H312+H332, H312, H332, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H302 + H312 + H332 Harmful if swallowed, in contact with skin or if inhaled. H373 May cause damage to organs through prolonged or repeated exposure. H373 May cause damage to organs (Kidney, Liver) through prolonged or repeated exposure if swallowed. none
Precautionary statements
P260 Do not breathe dust. P280 Wear protective gloves/ protective clothing. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P314 Get medical advice/ attention if you feel unwell. none
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Acute toxicity, Inhalation (Category 4), H332 Acute toxicity, Dermal (Category 4), H312 Specific target organ toxicity - repeated exposure (Category 2), H373 Specific target organ toxicity - repeated exposure, Oral (Category 2), Kidney, Liver, H373 For the full text of the H-Statements mentioned in this Section, see Section 16.